Educational Intervention for Asthmatic and Allergic Patients
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Despite its importance, there are few studies that implement the use of new technologies in the approach to patients with asthma and allergy. Therefore, the objective of this study is to evaluate the effectiveness of a telematic educational intervention in patients with allergies and / or asthma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Jun 2021
Shorter than P25 for not_applicable asthma
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2021
CompletedStudy Start
First participant enrolled
June 12, 2021
CompletedFirst Posted
Study publicly available on registry
June 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedJune 16, 2021
June 1, 2021
1 month
March 25, 2021
June 10, 2021
Conditions
Outcome Measures
Primary Outcomes (8)
Asthma knowledge questionnaire
Questionnaire to evaluate the knowledge about asthma. The questionnaire consists of 23 questions, some of them with several items. In total, there are 54 possible true / false / don't know answers. Each correct answer is given the value of one point and each incorrect or unknown answer a score of 0. Thus, the score that can be obtained in total is 0-54.
Baseline
Asthma knowledge questionnaire
Questionnaire to evaluate the knowledge about asthma. The questionnaire consists of 23 questions, some of them with several items. In total, there are 54 possible true / false / don't know answers. Each correct answer is given the value of one point and each incorrect or unknown answer a score of 0. Thus, the score that can be obtained in total is 0-54.
1month
Allergic rhinitis knowledge questionnaire
Questionnaire to evaluate the knowledge about Allergic rhinitis. It includes 7 items. Patients have to answer true/false. Higher puntuation indicates better knowledge results.
Baseline
Allergic rhinitis knowledge questionnaire
Questionnaire to evaluate the knowledge about Allergic rhinitis. It includes 7 items. Patients have to answer true/false. Higher puntuation indicates better knowledge results.
1month
Inhaler technique checklist
Checklist to evaluate the technique of inhaler. It contains several items that need to be checked. If the patient has a puntuation of 0-3 it is considered poor technique; If the patien has a puntuation of 4-5 it is considered the patient has a Moderate technique and if the patient has 6-7 points the technique is Good
Baseline
Inhaler technique checklist
Checklist to evaluate the technique of inhaler. It contains several items that need to be checked. If the patient has a puntuation of 0-3 it is considered poor technique; If the patien has a puntuation of 4-5 it is considered the patient has a Moderate technique and if the patient has 6-7 points the technique is Good
1month
Knowledge of COVID
Questionnaire to evaluate the knowledge about COVID-19. It includes 12 items. Patients have to answer true/false. Higher puntuation indicates better knowledge results.
Baseline
Knowledge of COVID
Questionnaire to evaluate the knowledge about COVID-19. It includes 12 items. Patients have to answer true/false. Higher puntuation indicates better knowledge results.
1month
Secondary Outcomes (14)
Asthma control questionnaire
Baseline
Asthma control questionnaire
1month
Allergic rhinitis control test
Baseline
Allergic rhinitis control test
1month
Fear of COVID-19 Scale
Baseline
- +9 more secondary outcomes
Study Arms (3)
Virtual educational intervention
EXPERIMENTALEducational intervention about the disease, the use of medication and the context of pandemic
Written educational intervention
EXPERIMENTALEducacional intervention about the disease, the use of medication and the context of pandemic
Control intervention
NO INTERVENTIONControl intervention
Interventions
Educational intervention about the disease, the use of medication and the context of pandemic
Educational intervention about the disease, the use of medication and the context of pandemic
Eligibility Criteria
You may qualify if:
- Asthmatic and allergic patients
You may not qualify if:
- Cognitive impairment.
- Diagnose of autism spectrum disorder or severe intellectual disability
- Physical or functional impairment that limits the performance of evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; PT; PhD
Study Record Dates
First Submitted
March 25, 2021
First Posted
June 16, 2021
Study Start
June 12, 2021
Primary Completion
July 12, 2021
Study Completion
July 30, 2021
Last Updated
June 16, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share